ImmuCell Corporation
US ˙ NasdaqCM ˙ US4525253062

Introduction

This page provides a comprehensive analysis of the known insider trading history of David Scott Tomsche. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate David Scott Tomsche has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ICCC / ImmuCell Corporation Director 131,797
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by David Scott Tomsche. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ICCC / ImmuCell Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ICCC / ImmuCell Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2020-03-11 ICCC Tomsche David Scott 4,600 4.2800 4,600 4.2800 19,688 345 11.8800 34,960 177.57
2020-02-27 ICCC Tomsche David Scott 5,130 4.9800 5,130 4.9800 25,547
2018-08-16 ICCC Tomsche David Scott 3,000 6.6700 3,000 6.6700 20,010
2017-03-14 ICCC Tomsche David Scott 150 5.4600 150 5.4600 819
2017-03-14 ICCC Tomsche David Scott 658 5.4500 658 5.4500 3,586
2017-03-14 ICCC Tomsche David Scott 389 5.4100 389 5.4100 2,104
2017-03-13 ICCC Tomsche David Scott 490 5.4000 490 5.4000 2,646
2017-03-13 ICCC Tomsche David Scott 313 5.4500 313 5.4500 1,706
2016-11-07 ICCC Tomsche David Scott 4,000 5.1900 4,000 5.1900 20,760
2016-03-21 ICCC Tomsche David Scott 955 6.6700 955 6.6700 6,370
2016-01-29 ICCC Tomsche David Scott 6,666 5.2500 6,666 5.2500 34,996
2015-09-01 ICCC Tomsche David Scott 1,000 6.7300 1,000 6.7300 6,730
2015-08-28 ICCC Tomsche David Scott 1,500 7.2700 1,500 7.2700 10,905
2014-05-15 ICCC Tomsche David Scott 1,000 3.5100 1,000 3.5100 3,510
2014-05-15 ICCC Tomsche David Scott 1,000 3.6300 1,000 3.6300 3,630
2014-05-15 ICCC Tomsche David Scott 1,000 3.5000 1,000 3.5000 3,500
2014-05-15 ICCC Tomsche David Scott 1,000 3.7100 1,000 3.7100 3,710

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ICCC / ImmuCell Corporation Insider Trades
Insider Sales ICCC / ImmuCell Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ICCC / ImmuCell Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ICCC / ImmuCell Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by David Scott Tomsche as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-08-30 2024-08-28 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 2,186 131,797 1.69 3.55 7,760 467,879
2024-08-26 2024-08-23 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 6,005 129,611 4.86 3.55 21,318 460,119
2024-08-22 2024-08-22 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 10,000 123,606 8.80 3.55 35,500 438,801
2024-08-19 2024-08-19 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 3,172 113,606 2.87 3.67 11,641 416,934
2024-08-19 2024-08-16 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 4,811 110,434 4.55 3.72 17,883 410,494
2024-08-19 2024-08-15 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 2,017 105,623 1.95 3.57 7,195 376,757
2023-09-06 2023-09-06 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 3,100 103,606 3.08 4.75 14,738 492,553
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 100 100,506 0.10 5.44 544 546,753
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 69 100,406 0.07 5.53 382 555,245
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 69 100,406 0.07 5.53 382 555,245
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 100 100,337 0.10 5.53 553 554,864
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 100 100,337 0.10 5.53 553 554,864
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 69 100,237 0.07 5.53 382 554,311
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 31 100,168 0.03 5.53 171 553,929
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 31 100,168 0.03 5.53 171 553,929
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 31 100,137 0.03 5.53 171 553,758
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 69 100,106 0.07 5.53 382 553,586
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 31 100,037 0.03 5.53 171 553,205
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 69 100,006 0.07 5.53 382 553,033
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 831 99,737 0.84 5.47 4,546 545,561
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 309 98,906 0.31 5.50 1,700 543,983
2023-03-15 2023-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 71 98,597 0.07 5.50 390 542,284
2023-03-15 2023-03-13 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 100 98,526 0.10 5.24 524 516,276
2023-03-15 2023-03-13 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 100 98,526 0.10 5.24 524 516,276
2023-03-15 2023-03-13 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 10 98,326 0.01 5.23 52 514,245
2023-03-15 2023-03-13 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 7 98,316 0.01 5.24 37 515,176
2023-03-15 2023-03-13 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 3 98,309 0.00 5.24 16 515,139
2023-03-15 2023-03-13 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 80 98,306 0.08 5.34 427 524,954
2023-03-15 2023-03-13 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 900 98,226 0.92 5.37 4,833 527,474
2023-03-15 2023-03-13 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 200 97,326 0.21 5.25 1,050 510,962
2023-03-15 2023-03-13 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 300 97,126 0.31 5.24 1,572 508,940
2023-03-15 2023-03-13 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 400 96,826 0.41 5.20 2,080 503,495
2022-09-12 2022-09-12 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 195 96,426 0.20 7.80 1,521 752,123
2022-09-12 2022-09-12 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 606 96,231 0.63 7.75 4,696 745,790
2022-09-12 2022-09-09 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 20 95,625 0.02 7.70 154 736,312
2022-09-12 2022-09-09 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 33 95,605 0.03 7.80 257 745,719
2022-09-12 2022-09-09 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 647 95,572 0.68 7.76 5,021 741,639
2022-09-12 2022-09-08 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 1 94,925 0.00 7.62 8 723,328
2022-09-12 2022-09-08 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 260 94,924 0.27 7.69 1,999 729,966
2022-09-12 2022-09-08 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 5 94,664 0.01 7.70 38 728,913
2022-09-12 2022-09-08 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 5 94,659 0.01 7.72 39 730,767
2022-09-12 2022-09-08 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 329 94,654 0.35 7.71 2,537 729,782
2022-09-12 2022-09-08 4 ICCC IMMUCELL CORP /DE/
Common Stock, $0.10 per value per share
D - Sale to Issuer 306 94,325 0.33 7.68 2,350 724,416
2022-06-16 2022-06-14 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 400 94,019 0.43 8.25 3,300 775,657
2022-06-16 2022-06-14 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 50 93,619 0.05 8.05 402 753,633
2022-06-16 2022-06-14 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 200 93,569 0.21 8.10 1,620 757,909
2022-06-16 2022-06-13 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 485 93,369 0.52 7.77 3,768 725,477
2022-06-16 2022-06-13 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 48 92,884 0.05 7.82 375 726,353
2022-06-16 2022-06-13 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 90 92,836 0.10 7.79 701 723,192
2022-06-16 2022-06-13 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 462 92,746 0.50 7.81 3,608 724,346
2022-06-16 2022-06-13 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 200 92,284 0.22 7.80 1,560 719,815
2022-06-16 2022-06-13 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 200 92,084 0.22 7.73 1,546 711,809
2022-06-16 2022-06-09 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 87 91,884 0.09 8.46 736 777,339
2022-06-16 2022-06-09 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 500 91,797 0.55 8.45 4,225 775,685
2022-06-16 2022-06-09 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 643 91,297 0.71 8.50 5,466 776,024
2022-06-16 2022-06-09 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 70 90,654 0.08 8.49 594 769,652
2022-06-16 2022-06-09 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 200 90,584 0.22 8.64 1,728 782,646
2022-06-16 2022-06-07 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 53 90,384 0.06 8.18 434 739,341
2022-06-16 2022-06-02 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 112 90,331 0.12 8.20 918 740,714
2022-06-16 2022-06-01 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 300 90,219 0.33 8.23 2,469 742,502
2022-06-16 2022-06-01 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 700 89,919 0.78 8.25 5,775 741,832
2022-06-16 2022-06-01 4 ICCC IMMUCELL CORP /DE/
Common stock $0.10 per value per share
D - Sale to Issuer 100 89,219 0.11 8.27 827 737,841
2022-05-18 2022-05-17 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
D - Sale to Issuer 3,400 104,119 3.38 8.37 28,458 871,476
2022-05-18 2022-05-16 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
D - Sale to Issuer 200 100,719 0.20 8.35 1,670 841,004
2022-05-18 2022-05-17 4/A ICCC IMMUCELL CORP /DE/
Common Stock, par valude $0.10 per share
D - Sale to Issuer 3,400 89,119 3.97 8.37 28,458 745,926
2022-05-18 2022-05-16 4/A ICCC IMMUCELL CORP /DE/
Common Stock, par valude $0.10 per share
D - Sale to Issuer 200 85,719 0.23 8.35 1,670 715,754
2021-06-21 2021-06-17 4 ICCC IMMUCELL CORP /DE/
Incentive Stock Options (Right to buy)
A - Award 10,000 10,000 10.04 100,400 100,400
2020-03-12 2020-03-11 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 4,600 85,519 5.68 4.28 19,688 366,021
2020-03-02 2020-02-27 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 5,130 80,919 6.77 4.98 25,547 402,977
2018-08-20 2018-08-16 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 3,000 75,789 4.12 6.67 20,010 505,513
2018-03-21 2018-03-19 4 ICCC IMMUCELL CORP /DE/
Incentive Stock Options (Right to buy)
A - Award 15,000 15,000 7.08 106,200 106,200
2018-03-21 2018-03-19 4 ICCC IMMUCELL CORP /DE/
Incentive Stock Options (Right to buy)
A - Award 15,000 15,000 7.08 106,200 106,200
2017-03-15 2017-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 389 72,789 0.54 5.41 2,104 393,788
2017-03-15 2017-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 658 72,400 0.92 5.45 3,586 394,580
2017-03-15 2017-03-14 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 150 71,742 0.21 5.46 819 391,711
2017-03-15 2017-03-13 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 313 71,592 0.44 5.45 1,706 390,176
2017-03-15 2017-03-13 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 490 71,279 0.69 5.40 2,646 384,907
2016-11-08 2016-11-07 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 4,000 70,789 5.99 5.19 20,760 367,395
2016-03-22 2016-03-21 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 955 66,789 1.45 6.67 6,370 445,483
2016-02-01 2016-01-29 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 6,666 65,834 11.27 5.25 34,996 345,628
2015-09-03 2015-09-01 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 1,000 59,168 1.72 6.73 6,730 398,201
2015-09-01 2015-08-28 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 1,500 58,168 2.65 7.27 10,905 422,881
2014-05-16 2014-05-15 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 1,000 56,668 1.80 3.71 3,710 210,238
2014-05-16 2014-05-15 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 1,000 55,668 1.83 3.50 3,500 194,838
2014-05-16 2014-05-15 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 1,000 54,668 1.86 3.63 3,630 198,445
2014-05-16 2014-05-15 4 ICCC IMMUCELL CORP /DE/
Common Stock, par value $0.10 per share
P - Purchase 1,000 53,668 1.90 3.51 3,510 188,375
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)